Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2013; 3(8):616-617. doi:10.7150/thno.7020 This issue Cite

Editorial

Nanoparticle-based Monitoring of Stem Cell Therapy

Chenjie Xu1✉, Weian Zhao2 ✉

1. Division of Bioengineering, School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637457.
2. Sue and Bill Gross Stem Cell Research Center, Chao Family Comprehensive Cancer Center, Edwards Lifesciences Center for Advanced Cardiovascular Technology, Department of Biomedical Engineering, and Department of Pharmaceutical Sciences, University of California, Irvine, CA USA 92697.

✉ Corresponding authors: Email: cjxuedu.sg; Email: weianzedu

Citation:
Xu C, Zhao W. Nanoparticle-based Monitoring of Stem Cell Therapy. Theranostics 2013; 3(8):616-617. doi:10.7150/thno.7020. https://www.thno.org/v03p0616.htm
Other styles

File import instruction

Abstract

This theme issue provides a timely overview on the current status of stem cell tracking with the nanoparticle-based contrast agents.

Citation styles

APA
Xu, C., Zhao, W. (2013). Nanoparticle-based Monitoring of Stem Cell Therapy. Theranostics, 3(8), 616-617. https://doi.org/10.7150/thno.7020.

ACS
Xu, C.; Zhao, W. Nanoparticle-based Monitoring of Stem Cell Therapy. Theranostics 2013, 3 (8), 616-617. DOI: 10.7150/thno.7020.

NLM
Xu C, Zhao W. Nanoparticle-based Monitoring of Stem Cell Therapy. Theranostics 2013; 3(8):616-617. doi:10.7150/thno.7020. https://www.thno.org/v03p0616.htm

CSE
Xu C, Zhao W. 2013. Nanoparticle-based Monitoring of Stem Cell Therapy. Theranostics. 3(8):616-617.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use